Assay

Financial-condition grades for SEC filers

Company Report · as of Oct 9, 2026


HomeCompaniesSectorsCalendarLast night

GridAI Technologies Corp.GRDX · utilities
GradeNonecomputable_factors_below_threshold: 6 of 14 inputs computable; 7 are required
Reliability0.83 AUCfailure model, filers with $12.5M to $120M assets; 95% interval 0.79 to 0.86; 201 events, 2020 to 2025
Peer failure rate1.07% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025
Size band$12.5M to $120M assetstotal assets $48.6M[1]
Standard universeoutsiderevenue above $1M and assets above $10M[1-2]
Warningsdilution, short runway, late filer, thin data, degenerate inputsnot computable: distress, fortress balance sheet
Inputs computable6 of 14
Graded fromfilings received through May 1, 2026161 days before the rescan; every figure keyed to the SEC receipt date
Last close$4.802026-10-08; market equity $34.2M; iex feed
Price used in gradeNone
Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history
$2$4$6NovDecJanFebMarAprMayJunJulAugSepOct$4.80
ABCDE20132014201520162017201820192020202120222023202420252026

Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date.

Open this report as it stood on

Letter setLetterPercentileBand
Jan 21, 2012nonen/a
Apr 21, 2017nonen/aQ1
Apr 21, 2021nonen/aQ2
Apr 21, 2022nonen/aQ1
Apr 21, 2025nonen/aQ2

Each date opens the report as it stood on that rescan.

Business, in the company's words. Opening of Item 1 of the 10-K received May 1, 2026; the document on sec.gov.

GridAI Technologies Corp., formerly known as Entero Therapeutics, Inc., is a diversified technology and life sciences company operating through two principal areas: (i) energy orchestration and grid optimization software solutions through our subsidiary Grid AI Corp. and (ii) legacy biopharmaceutical development activities centered on Adrulipase for the treatment of exocrine pancreatic insufficiency. Effective December 1, 2025, the Company changed its name from “Entero Therapeutics, Inc.” to “GridAI Technologies Corp.” and changed its Nasdaq trading symbol from “ENTO” to “GRDX.

Warnings [top]

Dilution. split-adjusted year-over-year share growth is 290.2%[3-4]
Short runway. cash runway is 2.0 months[5]
Late filer. found 5 NT 10-K/Q filings in the last eight quarters
Thin data. 6 of 14 grade factors are computable; minimum is 7
Degenerate inputs. latest revenue or assets are at or below the $100,000 validity floor[1-2]

7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.

The Fourteen Inputs [top]

Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.

InputPercentile, 0 to 100ValueSourcePeer medianPercentilePeersPeriod end
Profitability, sleeve percentile 93.2
Gross profitability(1.4%)[1,6]17.5%95.0812025-12-31
Return on invested capitalnot computable6.0%
one or more required annual facts are missing
Accruals ratio(1.0%)[1,7-9](5.0%)91.52712025-12-31
Gross margin stability, five yearsnot computable4.6 pts
five annual gross margins are required; found 1
Solvency, sleeve percentile 95.9
Twelve-month failure probabilitynot computable0.06%
latest liabilities, cash plus short-term investments, book equity, and shares are required
Altman Z double-prime(15.37)[1,10-15]1.4894.71522025-12-31
Net debt to EBITDAnot computable3.63x
one or more required annual facts are missing
Interest coveragenot computable2.37x
interest expense must exceed $100,000
Current ratio0.17x[10-11]0.97x97.22822025-12-31
Growth and financing, sleeve percentile 50.8
Revenue growth, three-year compoundnot computable0.7%
four annual observations are required; found 2
Free cash flow growth, three-year compoundnot computable(11.8%)
current FCF must be positive and base FCF must exceed $100,000
Reinvestment ratenot computable59.0%
NOPAT must exceed $100,000
Asset growth, three years107.4%[1,9,16-17]6.4%1.62462025-12-31
Net share issuance, one year290.2%[3-4]0.4%100.01572026-05-01

Gross profitability. Revenue less cost of goods sold, over total assets.

Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.

Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.

Twelve-month failure probability. CHS model; lower is stronger.

Net debt to EBITDA. Lower is stronger.

Net share issuance, one year. Split-adjusted; lower is stronger.

Among 148 Peers [top]

What the Price Implies [top]

Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.

MeasureValuePeer medianPercentileReading
Twelve-month price change, skipping the latest month(25.6%)15.5%6hotter than 6 of 100 peers
Distance from 52-week high(29.4%)(15.4%)18closer to its high than 18 of 100 peers
EBIT to enterprise valuenot computable4.6%required accounting or market input is missing
Free cash flow yield(94.5%)1.3%3pricier than 97 of 100 peers
Book value to price0.430.5330pricier than 70 of 100 peers
Sales to price0.000.450pricier than 100 of 100 peers
Composite equity issuance, five yearsnot computable(7.2%)five-year total-return history is required
Relative strength against the sector, log excess return(0.28)0.0415ahead of 15 of 100 peers

Inputs: market equity $34.2M; EBIT -$7.1M; free cash flow -$32.4M; book equity $14.9M; sales $36,251; cash $1.4M[18].

Diagnostics [top]

Diagnostics do not feed the grade.

Piotroski F-score: None of 9, period end 2025-12-31
Return on assets above zero(7.5%)✗ fail[7,9]
Operating cash flow above zero-$5.7M✗ fail[8]
Return on assets improved254.9 pts✓ pass[7,9,16,19]
Operating cash flow exceeds net income$689,830✓ pass[7-8]
Long-term leverage felln/a[1,9,16]
Current ratio improved(285.9 pts)✗ fail[10-11,20-21]
No new shares issued290.2%✗ fail[3-4]
Gross margin improvedn/a[2,6]
Asset turnover improvedn/a[2,9,16]
Cash, filings, liquidity
Cash and equivalents$1.4M[5]
Operating cash flow, four quarters-$8.1M[5,8,22-25]
Months of runway2.0
Late filings, two years5
NT 10-K or NT 10-Q
Days since last periodic filing49
10-Q received Aug 21, 2026
Median daily dollar volume$283,739
63 sessions
Days since newest grade input161

Downloads [top]

Sources [top]

Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.

#ConceptXBRL tagValuePeriod endReceivedFormLinks
1assetsus-gaap:Assets$48.6M2025-12-312026-05-0110-Kfiling · viewer · series
2revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax$36,2512025-12-312026-05-0110-Kfiling · viewer · series
3shares outstandingdei:EntityCommonStockSharesOutstanding6,200,0512026-05-012026-05-0110-Kfiling · viewer · series
4shares outstandingdei:EntityCommonStockSharesOutstanding4,765,7292025-04-012025-04-0910-K/Afiling · viewer · series
5cashus-gaap:CashAndCashEquivalentsAtCarryingValue$1.4M2026-06-302026-09-1810-Q/Afiling · viewer · series
6gross profitus-gaap:GrossProfit-$657,4322025-12-312026-05-0110-Kfiling · viewer · series
7net incomeus-gaap:NetIncomeLoss-$6.4M2025-12-312026-05-0110-Kfiling · viewer · series
8operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$5.7M2025-12-312026-05-0110-Kfiling · viewer · series
9assetsus-gaap:Assets$85.4M2024-12-312026-05-0110-Kfiling · viewer · series
10current assetsus-gaap:AssetsCurrent$2.6M2025-12-312026-05-0110-Kfiling · viewer · series
11current liabilitiesus-gaap:LiabilitiesCurrent$15.2M2025-12-312026-05-0110-Kfiling · viewer · series
12retained earningsus-gaap:RetainedEarningsAccumulatedDeficit-$208.8M2025-12-312026-05-0110-Kfiling · viewer · series
13operating incomeus-gaap:OperatingIncomeLoss-$7.1M2025-12-312026-05-0110-Kfiling · viewer · series
14book equityus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest$24.9M2025-12-312026-05-0110-Kfiling · viewer · series
15liabilitiesus-gaap:Liabilities$19.7M2025-12-312026-05-0110-Kfiling · viewer · series
16assetsus-gaap:Assets$6.9M2023-12-312025-04-0910-K/Afiling · viewer · series
17assetsus-gaap:Assets$5.4M2022-12-312024-03-2910-Kfiling · viewer · series
18shares outstandingdei:EntityCommonStockSharesOutstanding7,131,1232026-08-212026-09-1810-Q/Afiling · viewer · series
19net incomeus-gaap:NetIncomeLoss-$18.1M2024-12-312026-05-0110-Kfiling · viewer · series
20current assetsus-gaap:AssetsCurrent$83.5M2024-12-312026-05-0110-Kfiling · viewer · series
21current liabilitiesus-gaap:LiabilitiesCurrent$27.5M2024-12-312026-05-0110-Kfiling · viewer · series
22operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$3.3M2026-06-302026-09-1810-Q/Afiling · viewer · series
23operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$1.8M2026-03-312026-05-2710-Qfiling · viewer · series
24operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$1.7M2025-09-302025-11-1910-Qfiling · viewer · series
25operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$873,5132025-06-302026-09-1810-Q/Afiling · viewer · series

Limitations [top]

Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.

Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.

Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.

Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.

Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.